Literature DB >> 17914713

Misspecification tests for binomial and beta-binomial models.

Marinela Capanu1, Brett Presnell.   

Abstract

The IOS test of Presnell and Boss (J. Am. Stat. Assoc. 2004; 99(465):216-227) is a general-purpose goodness-of-fit test based on the ratio of in-sample and out-of-sample likelihoods. For large samples, the IOS statistic can be approximated by a multiplicative contrast between two estimates of the information matrix, and in this way the IOS test is connected to White's (Econometrica 1982; 50:1-26) information matrix test, or IM test, which is based directly on the difference of two estimates of the information matrix. In this paper, we compare the performance of IOS to that of the IM test and of other goodness-of-fit tests for binomial and beta-binomial models, in both examples and simulations. Our findings suggest that IOS is strongly competitive, not only against the IM test but also against tests designed for specific binomial and beta-binomial models.

Mesh:

Year:  2008        PMID: 17914713     DOI: 10.1002/sim.3049

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  4 in total

1.  Global goodness-of-fit tests for group testing regression models.

Authors:  Peng Chen; Joshua M Tebbs; Christopher R Bilder
Journal:  Stat Med       Date:  2009-10-15       Impact factor: 2.373

2.  Comprehensive approach to analyzing rare genetic variants.

Authors:  Thomas J Hoffmann; Nicholas J Marini; John S Witte
Journal:  PLoS One       Date:  2010-11-03       Impact factor: 3.240

3.  Comparing performance between log-binomial and robust Poisson regression models for estimating risk ratios under model misspecification.

Authors:  Wansu Chen; Lei Qian; Jiaxiao Shi; Meredith Franklin
Journal:  BMC Med Res Methodol       Date:  2018-06-22       Impact factor: 4.615

4.  Beta distribution misspecification tests with application to Covid-19 mortality rates in the United States.

Authors:  José Jairo Santana-E-Silva; Francisco Cribari-Neto; Klaus L P Vasconcellos
Journal:  PLoS One       Date:  2022-09-20       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.